Phosphoinositide 3-kinase (PI3K); phosphatase and tensin homolog deleted on chromosome ten (PTEN; MMAC1; TEP1); forkhead box O1 (FOXO1) BriefCommunication Pages: 439 - 439
SRY (sex determining region T)-box 9 (SOX9); preferentially expressed antigen in melanoma (PRAME) BriefCommunication Pages: 443 - 443
Transforming protein [Human papillomavirus type 16] (E6; HpV16gp1); E7 (HpV16gp2) BriefCommunication Pages: 447 - 447
Growth factor independent 1 transcription repressor (GFI1); microRNA-196b (miRNA-196b); miRNA-21 BriefCommunication Pages: 452 - 452
pfs 5′-methylthioadenosine/S-adenosylhomocysteine nucleosidase (MTAN) BriefCommunication Pages: 454 - 454
Prostaglandin E2 receptor EP2 subtype (PTGER2); PTGER4; IL-1 receptor 1 (IL1R1); IL-23 receptor (IL23R); IL-17 BriefCommunication Pages: 460 - 460
Mitogen-activated protein kinase kinase kinase 12 (MAP3K12; DLK); c-jun N-terminal kinase (JNK) BriefCommunication Pages: 462 - 462
Phosphodiesterase-4 (PDE4A; PDE-4), 5-hydroxytryptamine (serotonin) receptor (HTR; 5-HT) BriefCommunication Pages: 463 - 463
N-Methyl-D-aspartic acid receptor (NMDAR); glutamate receptor, ionotropic, N-methyl-D-aspartate 2B (GRIN2B; NR2B) BriefCommunication Pages: 464 - 464
Antibody-coupled Au-Fe3O4 nanoparticles for target-specific platin delivery BriefCommunication Pages: 470 - 470
High-yield production of recombinant adeno-associated virus (AAV) vectors BriefCommunication Pages: 471 - 471
Conversion of human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells into neural cells BriefCommunication Pages: 472 - 472
